Form 4 for EXOZ EXOZYMES INC.
Accepted 2026-04-08 06:27:39 ET · period of report 2026-04-01 · accession 0001493152-26-015630 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-08 06:27 | 2026-04-01 | EXOZ | Perriman Damien Alan | Chief Commercial Off | A - Grant | $8.44 | +8,887 | 0 | New | +$75.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | COMMON STOCK | 2026-04-01 | A | A | 8,887 | $8.44 | 0 | D | — | — |